Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Plasmacytoma × Magnetic Resonance Spectroscopy × Clear all

Sponsor

Conditions

Breast Neoplasms 23 Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 13 Glioma 12 Neoplasm Metastasis 11 Lymphoma 10 Glioblastoma 10 Neuroblastoma 9 Lung Neoplasms 8 Carcinoma, Renal Cell 8 Brain Neoplasms 8 Medulloblastoma 7 Ovarian Neoplasms 6 Neoplasms 6 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Fallopian Tube Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Sarcoma 5 Rectal Neoplasms 5 Osteosarcoma 5 Neuroendocrine Tumors 5 Melanoma 5 Ependymoma 5 Central Nervous System Neoplasms 5 Wilms Tumor 4 Triple Negative Breast Neoplasms 4 Rhabdomyosarcoma 4 Rhabdoid Tumor 4

Interventions

Dexamethasone 3 dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 Calcium Dobesilate 2 Bortezomib 2 pomalidomide 1 navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1 ixazomib 1 daratumumab 1 carfilzomib 1 Specimen Handling 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Melphalan 1 Lenalidomide 1 Gemcitabine 1 Busulfan 1 Biopsy 1 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡